In detail, Dasatinib was conjugated with a specific oligonucleotide complementary (anti-sense) to an mRNA overexpressed in cancer cells (human BIRC5 mRNA, highly expressed in many cancers, and AML1/ETO translocation, present with high frequency in acute myeloid leukemia) [116,117]. This evidence concerns the gene RUNX1T1 and cancer.